TAVR may be a safe, effective treatment strategy for patients with moderate aortic stenosis and at least one other warning sign of heart disease. That was the key takeaway from a highly anticipated late-breaking study presented by Philippe Généreux, MD, at TCT 2026 in San Diego. 

Men are much more likely to have degenerative mitral valve disease than men, according to a new global analysis presented at TCT 2026 in San Diego. However, women are more likely to die from it. 

Patients with heart failure are especially vulnerable to the effects of poverty. Is the U.S. healthcare system doing enough to help these individuals?

The upfront costs may be higher, but new data presented at TCT 2026 showed that treating asymptomatic patients with TAVR instead of clinical surveillance was a highly cost-effective intervention. 

“A drug that can both decrease the risk for diabetes along with the risk for having a heart attack or stroke could be a turning point in our ability to safely treat this growing population in the U.S. and abroad,” one researcher said.

The new device can treat varying anatomies and is able to compensate for native leaflet abnormalities. It was also designed to be gentle on a patient's anatomy.

Alasnag, a veteran interventional cardiologist and women's health advocate, has won the 2027 Dr. Carolyn McCue Award for Woman Cardiologist of the Year. She directs the cardiac cath lab at King Fahd Armed Forces Hospital in Jeddah, Saudi Arabia.

The prospective trial will include up to 585 patients in the United States, Canada and Europe. 

The next-generation surgical device from Corcym was associated with consistent durability and positive safety data. For example, freedom from structural valve deterioration was seen in 99.7% of patients.

This Class II recall was initiated due to a risk of clinicians encountering issues when deploying the Trilogy Transcatheter Heart Valve System. 

Cardiology services for approximately 50,000 patients are in the middle of an ongoing legal battle. New York Sen. Jim Tedisco is now publicly calling for New York. Gov. Kathy Hochul to step in and help. 

The statistical shift was largely driven by a single $3.9 billion acquisition.

CT interpretations in the emergency department have significantly longer turnaround times when reads are completed off-site, new research suggests.